Titel

Merkliste
1 Ergebnisse

Fig 3 -:

Machiko Kai ; Hayato Hikita ; Maesaka Kazuki...
doi:10.1371/journal.pone.0294590.g003. , 2024

Link: https://doi.org/10.1371/journal.pone.0294590.g003

RT Journal
T1 <Title>Fig 3 -</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_24928223&Exemplar=1&LAN=DE
				
A1 Machiko Kai
A1 Hayato Hikita
A1 Maesaka Kazuki
A1 Yuki Tahata
A1 Kazuma Shinkai
A1 Akira Doi
A1 Kazuyoshi Ohkawa
A1 Masanori Miyazaki
A1 Hisashi Ishida
A1 Kengo Matsumoto
A1 Yasutoshi Nozaki
A1 Takayuki Yakushijin
A1 Ryotaro Sakamori
A1 Akira Kaneko
A1 Sadaharu Iio
A1 Takatoshi Nawa
A1 Naruyasu Kakita
A1 Naoki Morishita
A1 Naoki Hiramatsu
A1 Takeo Usui
A1 Kazuho Imanaka
A1 Yoshinori Doi
A1 Mitsuru Sakakibara
A1 Yuichi Yoshida
A1 Tsugiko Oze
A1 Takahiro Kodama
A1 Tomohide Tatsumi
A1 Tetsuo Takehara
YR 2024
K1 Ecology
K1 Immunology
K1 Cancer
K1 Science Policy
K1 Biological Sciences not elsewhere classified
K1 unresectable hepatocellular carcinoma
K1 severe adverse events
K1 objective response rate
K1 independent risk factors
K1 grade &# 8805
K1 disease control rate
K1 clinical factors associated
K1 atezolizumab plus bevacizumab
K1 absent macrovascular invasion
K1 9 months vs
K1 6 %
K1 respectively
K1 3 months vs
K1 0 months vs
K1 shortened overall survival
K1 median overall survival
K1 8 months )
K1 7 months )
K1 overall survival
K1 7 months
K1 free survival
K1 6 )
K1 shortened progression
K1 median progression
K1 xlink ">
K1 world practice
K1 study aimed
K1 older age
K1 lymphocyte ratio
K1 lower number
K1 lower neutrophil
K1 intrahepatic tumors
K1 higher number
K1 higher neutrophil
K1 75 years
K1 400 ng
K1 19 hospitals
K1 03 )
K1 0 %)
JF doi:10.1371/journal.pone.0294590.g003
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0294590.g003
DO https://doi.org/10.1371/journal.pone.0294590.g003
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)